Agenda of the HMPC meeting 22-24 September 2026
Agenda of the HMPC meeting 22-24 September 2026
Agenda of the HMPC meeting 22-24 September 2026
Records of data processing activity Industry Single Point of Contact (i-SPOC) reporting system
European Medicines Agency’s privacy statement for the Industry Single Point of Contact (i-SPOC) system
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Date of authorisation: 28/08/2026, Status: Authorised
Assessment templates and guidance
SME info day - navigating EMA support: From innovation to marketing authorisation, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 6 November 2026, 09:15 (CET) to 6 November 2026, 16:00 (CET)
Sixth veterinary big data stakeholder forum, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2026, 09:00 (CET) to 10 November 2026, 17:30 (CET)
Human normal immunoglobulins
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised